LSE:SNG - Synairgen plc Synairgen plc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

GBX 154.0    +2 (+1.32%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

23 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Richard Marsden

Headquarters: UK

Employees: 18

Homepage

Description

Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, LOXL2 inhibitor, and others.